banner3

Upcoming Events

 

Frank Reynolds, InVivo CEO, to appear on local TV affiliates

CEO to Discuss the Company’s Latest Advances on April 14, 16 and 17, Respectively

CAMBRIDGE, Mass. (April 11, 2011) – InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on local TV affiliates in Charlotte, Indianapolis and Greensboro. The planned schedule includes:

  • WBTV-TV, the CBS affiliate in Charlotte, NC, on Saturday, April 14, at 6:50 AM EDT
  • WXIN-TV, the FOX affiliate in Indianapolis, IN, on Monday, April 16, at 9:45 AM EDT
  • WFMY-TV, the CBS affiliate in Greensboro, NC, on Tuesday, April 17, at 7:45 AM EDT

InVivo Therapeutics has pioneered a new treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after a traumatic spinal cord injury. In addition to the scaffold, Reynolds will discuss the company’s portfolio of technologies for other areas of the nervous system, including innovative injectable hydrogel products the company intends to submit to the U.S. Food and Drug Administration (FDA) in 2012.

“Our technology is a true platform that can be leveraged to create many products, including hydrogel treatments for peripheral nerve injury and other conditions. We’re currently under review at FDA for our first spinal cord injury treatment, and we look forward to receiving approval to begin those human studies,” said Reynolds.

Challenges

Active Challenges: 7

Award Total: $105,000

Sample Challenges:
+ Earn $20,000 by referring a Chairman of the Board
+ Earn $10,000 by referring an Advisory Board member

Login or call your Venture Advisor at (212) 326-9200 to participate.

Registration required.



More about Challenges

Join Spencer Trask

Join the Spencer Trask Angel Network

join_our_network

 

 

Follow Us

sm-facebook

sm-twitter

sm-linkedin

sm-youtube